These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9188502)
1. Activation transcription factor 1 involvement in the regulation of murine H-2Dd expression. Ishiguro N; Brown GD; Meruelo D J Biol Chem; 1997 Jun; 272(25):15993-6001. PubMed ID: 9188502 [TBL] [Abstract][Full Text] [Related]
2. The regulation of murine H-2Dd expression by activation transcription factor 1 and cAMP response element binding protein. Ishiguro N; Brown GD; Ishizu A; Meruelo D J Immunol; 1998 Jun; 160(12):5907-14. PubMed ID: 9637503 [TBL] [Abstract][Full Text] [Related]
3. A novel DNA binding activity is elevated in thymocytes expressing high levels of H-2Dd after radiation leukemia virus infection. Nobunaga T; Brown GD; Morris DR; Meruelo D J Immunol; 1992 Aug; 149(3):871-9. PubMed ID: 1634776 [TBL] [Abstract][Full Text] [Related]
4. Transduction of a murine dominant negative activation transcription factor 1 increases cell surface expression of the class I MHC on a human epidermoid tumor cell line. Ishizu A; Sawai K; Ikeda H; Hirano T; Ishiguro N; Meruelo D Int Immunol; 2000 Feb; 12(2):161-8. PubMed ID: 10653851 [TBL] [Abstract][Full Text] [Related]
5. In vivo stimulation of H-2Dd expression following RadLV infection of thymocytes: increased transcription and DNA-binding activity to sequences 5' of the Dd gene. Brown GD; Nobunaga T; Morris DR; Meruelo D Res Immunol; 1991; 142(5-6):431-40. PubMed ID: 1754716 [TBL] [Abstract][Full Text] [Related]
6. Conservation of the H-2 BF1 binding motif 5' of the H-2Ds, Ks and Dq genes. Brown GD; Morris DR; Meruelo D Eur J Immunogenet; 1997 Aug; 24(4):241-57. PubMed ID: 9306093 [TBL] [Abstract][Full Text] [Related]
7. H-2D control of leukaemia susceptibility: mechanism and implications. Meruelo D J Immunogenet; 1980 Feb; 7(1):81-90. PubMed ID: 6154752 [TBL] [Abstract][Full Text] [Related]
8. Role of the Q10 class I regulatory element region 1 in controlling tissue-specific expression in vivo. Marine JB; Shirakata Y; Wadsworth SA; Hooley JJ; Handy DE; Coligan JE J Immunol; 1993 Aug; 151(4):1989-97. PubMed ID: 8345192 [TBL] [Abstract][Full Text] [Related]
9. A third class I major histocompatibility complex antigen encoded by a gene in the D region of the H-2d haplotype recognized by cytotoxic T lymphocytes. Mann DW; Forman J Immunogenetics; 1988; 28(1):38-45. PubMed ID: 3259946 [TBL] [Abstract][Full Text] [Related]
10. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A. Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes. Li M; Muller J; Xu F; Hearing VJ; Gorelik E Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142 [TBL] [Abstract][Full Text] [Related]
12. The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cell surface expression: roles of TAP, Tapasin and beta2-microglobulin. Prasanna SJ; Nandi D Mol Immunol; 2004 Aug; 41(10):1029-45. PubMed ID: 15302165 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of H-2Dd and H-2Ld histocompatibility antigens. Weis JH; Murre C J Exp Med; 1985 Feb; 161(2):356-65. PubMed ID: 3919140 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A. Proffitt JL; Sharma E; Blair GE Nucleic Acids Res; 1994 Nov; 22(22):4779-88. PubMed ID: 7984430 [TBL] [Abstract][Full Text] [Related]
15. Recovery from Friend disease in mice with reduced major histocompatibility complex class I expression. Hasenkrug KJ; Sprangrude GJ; Nishio J; Brooks DM; Chesebro B J Virol; 1994 Apr; 68(4):2059-64. PubMed ID: 8138991 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors. Napolitano G; Montani V; Giuliani C; Di Vincenzo S; Bucci I; Todisco V; Laglia G; Coppa A; Singer DS; Nakazato M; Kohn LD; Colletta G; Monaco F Mol Endocrinol; 2000 Apr; 14(4):486-505. PubMed ID: 10770487 [TBL] [Abstract][Full Text] [Related]
17. Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis. Koeller D; Lieberman R; Miyazaki J; Appella E; Ozato K; Mann DW; Forman J J Exp Med; 1987 Sep; 166(3):744-60. PubMed ID: 2442290 [TBL] [Abstract][Full Text] [Related]
18. The NK cell MHC class I receptor Ly49A detects mutations on H-2Dd inside and outside of the peptide binding groove. Matsumoto N; Yokoyama WM; Kojima S; Yamamoto K J Immunol; 2001 Apr; 166(7):4422-8. PubMed ID: 11254697 [TBL] [Abstract][Full Text] [Related]
19. Promoter elements and transcription factors involved in differentiation-dependent human chorionic gonadotrophin-alpha messenger ribonucleic acid expression of term villous trophoblasts. Knöfler M; Saleh L; Bauer S; Vasicek R; Griesinger G; Strohmer H; Helmer H; Husslein P Endocrinology; 2000 Oct; 141(10):3737-48. PubMed ID: 11014230 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells. Kelly D; Kim SJ; Rizzino A J Biol Chem; 1998 Aug; 273(33):21115-24. PubMed ID: 9694866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]